Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from pooled donors, in EGM^®-2 Media and containing ≥ 500,000 cells

Cryopreserved ampoule of Human Umbilical Vein Endothelial Cells (HUVEC), from a single donor, in EGM^®-2 Media, containing ≥ 500,000 cells

Cryopreserved ampoule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells

Cryopreserved ampoule of Normal Human Lung Fibroblasts (NHLF) containing ≥ 500,000 cells

Cryopreserved ampoule of Human Skeletal Muscle Myoblasts containing ≥ 500,000 cells

Cryopreserved ampoule of Normal Adult Human Dermal Fibroblasts (NHDF-Ad) containing ≥ 500,000 cells

Cryopreserved ampule of Normal Human Bronchial Epithelial (NHBE) cells with Retinoic Acid containing ≥500,000 cells

Cryopreserved ampule of Human Lung Microvascular Endothelial Cells (HMVEC-L) containing ≥ 500,000 cells

Cryopreserved ampule of Small Airway Epithelial Cells (SAEC) containing ≥500,000 cells.

Cryopreserved human hepatocytes, plateable and interaction qualified are characterized for 3 major mechanisms of drug-drug interactions: transporter activity, enzyme activity, and induction potential (guaranteed to exhibit a 4 fold or greater change in induction activity), providing you with one product to meet more of your hepatocyte DDI study needs. Each ampule contains >5 million cells.